These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24587571)

  • 1. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
    Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
    Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
    Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
    Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
    Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
    Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
    Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
    Leufkens TR; Vermeeren A
    Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapses of attention as outcome measure of the on-the-road driving test.
    Verster JC; Bervoets AC; de Klerk S; Roth T
    Psychopharmacology (Berl); 2014 Jan; 231(1):283-92. PubMed ID: 23975036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
    Leufkens TR; Vermeeren A
    J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability.
    Verster JC; van de Loo AJ; Moline ML; Roth T
    Curr Drug Saf; 2014; 9(3):205-11. PubMed ID: 24909576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.
    Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
    Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
    Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
    Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
    Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control: Study Protocol Clinical Trial (SPIRIT Compliant).
    Iwata M; Iwamoto K; Kambe D; Tachibana N; Ando M; Ozaki N
    Medicine (Baltimore); 2020 Mar; 99(12):e19395. PubMed ID: 32195934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T; Steinberg F; Singh NN; Moline M
    Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades.
    Bocca ML; Le Doze F; Etard O; Pottier M; L'Hoste J; Denise P
    Psychopharmacology (Berl); 1999 Apr; 143(4):373-9. PubMed ID: 10367554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
    J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.